Bowel Preparation for Colonoscopy in the Elderly

Sponsor
Kyunghee University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02290093
Collaborator
Kangbuk Samsung Hospital (Other), Hanyang University (Other)
230
3
3
13
76.7
5.9

Study Details

Study Description

Brief Summary

The success of colonoscopy is closely related to the quality of colonic preparation. However, data regarding colonoscopy preparations in the elderly (65 years older) are scarce. Split-dosage cathartic bowel preparation are currently suggested, whereas supporting evidence is lacking in this particular group of patients. Moreover, patient tolerability is a key factor for success of bowel preparation in the aged people.

The purpose of this study is to compare the bowel cleansing efficacy and patient compliance of following bowel preparation methods prior to elective outpatient colonoscopy in the elderly: (1) standard preparation of 4 liters (L) PEG-3350 solution on the night before colonoscopy, (2) split-dose of 4L PEG-3350 solution, and (3) split-dose of reduced volume [2L] PEG-3350 containing ascorbic acid solution.

Condition or Disease Intervention/Treatment Phase
  • Drug: Standard full-volume PEG
  • Drug: Split-dose full-volume PEG
  • Drug: Split-dose low-volume PEG
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
230 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Diagnostic
Official Title:
Bowel Preparation With Standard 4 Liters of PEG vs. Split-dose of 4 Liters PEG vs. Split-dose of 2 Liters PEG Containing Ascorbic Acid Solutions for Outpatient Elective Colonoscopy in the Elderly: A Randomized, Colonoscopist-blinded Study
Study Start Date :
Nov 1, 2014
Actual Primary Completion Date :
Sep 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard full-volume PEG

Drug: Standard full-volume PEG
Subjects will be asked to take 4L of PEG-3350 solution the day prior to procedure.

Experimental: Split-dose full-volume PEG

Drug: Split-dose full-volume PEG
Subjects will be asked to take 2L of PEG-3350 solution the day prior to procedure, followed by another 2L of PEG-3350 solution on the day of the procedure.

Experimental: Split-dose low-volume PEG

Drug: Split-dose low-volume PEG
Subjects will be asked to take 1L of PEG-3350 containing ascorbic acid solution the day prior to procedure, followed by another 1L of PEG-3350 containing ascorbic acid solution on the day of the procedure.

Outcome Measures

Primary Outcome Measures

  1. Proportion of adequate bowel preparation quality at the time of colonoscopy defined by the Boston bowel preparation scale (BBPS). [1 year]

    The BBPS assesses cleanliness of 3 segments of the colon (ascending, transverse, and descending colon), and the total is a 10-point scale (0-9) that grades each segment of the colon from 0 to 3. In this study, adequate bowel preparation is defined as a total score 6 points or higher and individual score of 2 points or higher in each segment.

Secondary Outcome Measures

  1. Patient satisfaction with recommended bowel preparation method based on the 10-point visual analog scale [1 year]

  2. Rate of adverse events related to bowel preparation for colonoscopy [1 year]

    Adverse events include tenesmus, sleep disturbance, nausea, vomiting, abdominal cramping, abdominal fullness, abdominal discomfort, headache, dizziness, and others.

  3. Number of patients who have a willingness to repeat same bowel preparation method method [1 year]

  4. Consumed volume of recommended bowel preparation agent based on the 3-grade scale [1 year]

    The 3-grade scale: optimal (100%), good (≥ 75%), and poor (< 75%)

  5. Difficulty of completing ingestion of recommended bowel preparation agent based on the 3-grade scale [1 year]

    The 3-grade scale: never, some, and much

  6. Taste of recommended bowel preparation agent based on the 3-grade scale [1 year]

    The 3-grade scale: bad, neutral, and good

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • elderly people aged over 65 years

  • elective outpatient colonoscopy

  • informed consent

Exclusion Criteria:
  • patients who had bowel movements of less than 3 per week during last one month

  • patients who have a history of renal dysfunction (abnormal elevation of serum creatinine and electrolyte imbalance)

  • patients who have a history of alimentary tract surgery

  • patients who have other gastrointestinal diseases that are not suitable for undergoing colonoscopy (gastroparesis, gastric outlet obstruction, ileus, ischemic colitis, megacolon, and toxic colitis)

  • patients classified as the American Society for Anesthesiology class III or higher

  • Any condition which, in the opinion of the Investigator, places the patient at unacceptable risk if he/she were to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hanyang University Guri Hospital Guri Korea, Republic of
2 Kangbuk Samsung Hospital Seoul Korea, Republic of 110-746
3 Kyung Hee University Hospital Seoul Korea, Republic of 130-702

Sponsors and Collaborators

  • Kyunghee University Medical Center
  • Kangbuk Samsung Hospital
  • Hanyang University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Chang Kyun Lee, Associate professor, Kyunghee University Medical Center
ClinicalTrials.gov Identifier:
NCT02290093
Other Study ID Numbers:
  • 4LPEG-2LPEGA-Elderly-2014
First Posted:
Nov 13, 2014
Last Update Posted:
Feb 24, 2016
Last Verified:
Feb 1, 2016
Keywords provided by Chang Kyun Lee, Associate professor, Kyunghee University Medical Center

Study Results

No Results Posted as of Feb 24, 2016